Bill Search

HB 1239
  • Introduced
    Feb 06, 2025
  • Passed House
    Apr 07, 2025
  • Passed Senate
    Apr 07, 2025
  • Signed into Law
    Apr 24, 2025
HB 1239
Tennessee House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Last Action See all actions
executive • Apr 28, 2025: Effective date(s) 07/01/2025
Latest Bill Text See all bill texts
Amended with HA0252 -- 04/07/2025

Summary/Bill Text

Comments on HB 1239

Tweets

Whip Lists

Sponsors
Votes
Mar 11, 2025, Senate
SENATE JUDICIARY COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/11/2025 Passed (1)
YES: 9
NO: 0
OTHER: 0
YES: 9

NO: 0

    OTHER: 0
    Sources
    Actions
    • Apr 28, 2025 | executive
      • Pub. Ch. 295
      • Effective date(s) 07/01/2025
    • Apr 24, 2025 | executive
      • Signed by Governor.
    • Apr 16, 2025 | House
      • Sponsor(s) Added.
      • Transmitted to Governor for his action.
    • Apr 14, 2025 | Senate
      • Signed by Senate Speaker
    • Apr 10, 2025 | House
      • Signed by H. Speaker
    • Apr 08, 2025 | House
      • Enrolled; ready for sig. of H. Speaker.
    • Apr 07, 2025 | Senate
      • Received from House, Passed on First Consideration
      • Senate substituted House Bill for companion Senate Bill.
      • Amendment withdrawn. (Amendment 1 - SA0095)
      • Passed Senate, Ayes 27, Nays 4
    • Apr 07, 2025 | House
      • H. adopted am. (Amendment 1 - HA0252)
      • Passed H., as am., Ayes 92, Nays 1, PNV 0
      • Sponsor(s) Added.
      • Engrossed; ready for transmission to Sen.
    • Apr 03, 2025 | House
      • H. Placed on Regular Calendar for 4/7/2025
    • Apr 02, 2025 | House
      • Placed on cal. Calendar & Rules Committee for 4/3/2025
    • Apr 01, 2025 | House
      • Rec. for pass. if am., ref. to Calendar & Rules Committee
    • Mar 26, 2025 | House
      • Placed on cal. Health Committee for 4/1/2025
    • Mar 25, 2025 | House
      • Action def. in Health Committee to 4/1/2025
    • Mar 19, 2025 | House
      • Rec for pass if am by s/c ref. to Health Committee
      • Placed on cal. Health Committee for 3/25/2025
    • Mar 12, 2025 | House
      • Placed on s/c cal Health Subcommittee for 3/19/2025
    • Feb 12, 2025 | House
      • P2C, ref. to Health Committee
      • Assigned to s/c Health Subcommittee
    • Feb 10, 2025 | House
      • Intro., P1C.
    • Feb 06, 2025 | House
      • Filed for introduction
    Bill Texts
    Documents
    Sources